Cabot
CBT
75.41
-1.70
-2.20%
Cabot
US · CBT
#2289 by market cap
Listed 1970
75.41
-1.70
-2.20%
Live - 5344 symbols - heartbeat 293s ago
· 2026-10-08 07:00
Pre-market
75.00
-0.54%
After-hours
75.41
0.00%
- Market cap
- 3.89B
- P/E (TTM)i
- 21.12
- P/Bi
- 2.43
- EPSi
- 6.02
- Div yieldi
- 2.42%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on CBT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 105.02% +0.01pp
- Institutions
- 456
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund94.35%
Hedge Fund3.11%
Public Company2.48%
Government Pension Fund1.81%
Individual/Insider1.44%
Sovereign Wealth Fund1.12%
Family Office/Trust1.06%
Private Company0.87%
Insurance Company0.17%
Top holders as of 2026-06-30
BlackRock
13.51% · 6.97M sh
EARNEST Partners, LLC
6.48% · 3.35M sh
Vanguard Portfolio Management, LLC
5.96% · 3.08M sh
American Century Investment Management
5.36% · 2.77M sh
Vanguard Capital Management, LLC
5.16% · 2.67M sh
Wellington Management Group
4.68% · 2.42M sh
T. Rowe Price Group, Inc.
4.32% · 2.23M sh
State Street Global Advisors
4.19% · 2.17M sh
Fuller & Thaler Asset Management, Inc.
3.88% · 2.00M sh
Dimensional Fund Advisors
3.73% · 1.93M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 47 buys · 3 sells
| Name | Role | Stake |
|---|---|---|
| Sean Keohane | Chief Executive Officer | 0.81% |
| Jeff Zhu | Executive VP and President of Performance Chemicals Segment & Asia Pacific Region | 0.13% |
| Erica McLaughlin | Executive VP, CFO & Head of Corporate Strategy | 0.10% |
| Hobart Kalkstein | Executive VP and President of Reinforcement Materials Segment & Americas Region | 0.09% |
| Karen Kalita | General Counsel | 0.06% |
| William Kirby | Independent Director | 0.05% |
| Frank Wilson | Independent Director | 0.04% |
| Christine Yan | Independent Director | 0.03% |
| Cynthia Arnold | Independent Director | 0.03% |
| Lisa Dumont | Vice President | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Raffiq Nathoo | Independent Director | Other Derivative Acquisition | +360 | -- |
| 2026-09-29 | Sean Keohane | Chief Executive Officer | Other Derivative Acquisition | +346 | -- |
| 2026-09-29 | Erica McLaughlin | Executive VP, CFO & Head of Corporate Strategy | Other Derivative Acquisition | +93 | -- |
| 2026-09-29 | Karen Kalita | General Counsel | Other Derivative Acquisition | +44 | -- |
| 2026-09-29 | William Masterson | Senior VP & President of Reinforcement Materials Segment | Other Derivative Acquisition | +24 | -- |
| 2026-09-10 | Raffiq Nathoo | Independent Director | Other Derivative Acquisition | +11 | -- |
| 2026-09-10 | Douglas Del Grosso | Independent Director | Other Derivative Acquisition | +30 | -- |
| 2026-09-10 | Sean Keohane | Chief Executive Officer | Other Derivative Acquisition | +283 | -- |
| 2026-09-10 | Erica McLaughlin | Executive VP, CFO & Head of Corporate Strategy | Other Derivative Acquisition | +61 | -- |
| 2026-09-10 | Karen Kalita | General Counsel | Other Derivative Acquisition | +31 | -- |
| 2026-09-10 | Lisa Dumont | Vice President | Other Derivative Acquisition | +4 | -- |
| 2026-09-10 | William Masterson | Senior VP & President of Reinforcement Materials Segment | Other Derivative Acquisition | +3 | -- |
| 2026-08-27 | Sean Keohane | Chief Executive Officer | Derivative Exercise and Sale | -134,895 | $50.00–85.00 |
| 2026-08-23 | Sean Keohane | Chief Executive Officer | Derivative Exercise and Sale | -2,779 | $50.00–85.50 |
| 2026-08-06 | Sean Keohane | Chief Executive Officer | Derivative Exercise and Sale | -91,923 | $62.24–86.41 |
| 2026-06-29 | Raffiq Nathoo | Independent Director | Other Derivative Acquisition | +261 | -- |
| 2026-06-29 | Sean Keohane | Chief Executive Officer | Other Derivative Acquisition | +83 | -- |
| 2026-06-11 | Raffiq Nathoo | Independent Director | Other Derivative Acquisition | +8 | -- |
| 2026-06-11 | Douglas Del Grosso | Independent Director | Other Derivative Acquisition | +27 | -- |
| 2026-06-11 | Sean Keohane | Chief Executive Officer | Other Derivative Acquisition | +256 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:03 · For reference only, not investment advice and not tailored to your situation.